ETHYL 3-(4-FLUOROPHENYL)-2,2-DIMETHYLPROPANOATE, 95%, 1g

1H-Indazole-7-carboxylic acid, 96.0%, 5g

7-Hydroxy-3-(4-methoxy-phenoxy)-chromen-4-one, 95.0%, 250mg

CDTA, min. 99%, for synthesis, 500 g, plastic packaging.

7-Methyl-6-oxooctanoic acid, 97.0%, 100mg

2,5,8-Trioxa-11-azadodecane, 95%, 1g

3-(2-Oxo-benzothiazol-3-yl)-propionic acid, 1g

5-(Bromomethyl)-3-(4-methoxyphenyl)-1,2-oxazole, 97%, 100mg

Diethyl (Chloromethyl)phosphonate>98.0%(GC)5g

2,6-Difluoro-isonicotinic acid, 95.0%, 10g

Ethyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, 95%, 25g

2,3-Dichloro-4-fluoronitrobenzene, 95.0%, 10g

1-(2-Methoxyethyl)piperidin-4-one, 98%, 5g